Alertas Bibliográficas
DIABETES
Understanding the cause of type 2 diabetes.
Taylor R.
Lancet Diabetes And Endocrinol. 2024.
doi:10.1016/s2213-8587(24)00157-8
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Abdul-Ghani M, Maffei P, DeFronzo RA.
Lancet Diabetes Endocrinol. 2024 Aug 1:S2213-8587(24)00127-X.
doi: 10.1016/S2213-8587(24)00127-X
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1
Phillip M, Achenbach P, Addala A et al.
Diabetes. Diabetes Care. 2024.
doi:10.2337/dci24-004
ENDOCRINOLOGÍA
Genomic Considerations in the Treatment of Thyroid Carcinoma.
Hattum CJ, Elsey RJ, Meissner T, Spanos WC.
JCO Oncol Pract. 2024;20(7):873-875.
https://www.doi.org/10.1200/OP.24.00198
Polycystic ovary syndrome
Stener-Victorin E, Teede H, Norman RJ, et al. P
Nat Rev Dis Primers. 2024 Apr 18;10(1):27.
https://www.doi.org/10.1038/s41572-024-00511-3
Graves disease: latest understanding of pathogenesis and treatment options. Nat Rev Endocrinol.
Lanzolla G, Marinò M, Menconi F.
Published online July 22, 2024.
doi:10.1038/s41574-024-01016-5
PEDIATRÍA
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al.
N Engl J Med. 2019 Aug 15;381(7):637-646.
http://doi.org/10.1056/NEJMoa1903822
Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
Corica D, Aversa T, Ruggeri RM, Cristani M, Alibrandi A, et al.
Front Endocrinol (Lausanne). 2019 Jun 28;10:426.
http://doi.org/10.3389/fendo.2019.00426
CIENCIAS BÁSICAS
Mechanisms of Insulin Action and Insulin Resistance.
Petersen MC, Shulman GI.
Physiol Rev. 2018 Oct 1;98(4):2133-2223.
http://doi.org/10.1152/physrev.00063.2017
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Buzzetti E, Pinzani M, Tsochatzis EA.
Metabolism. 2016 Aug;65(8):1038-48.
http://doi.org/10.1016/j.metabol.2015.12.012